Play Video
The second Proof-of-Concept study using INV043 API undertaken in October 2021 produced an unexpected result, according to Dr Andrew Stephens from Hudson Institute.
Video interview with Dr Andrew Stephens from Hudson Institute who explained why he’s excited about the inital Proof-of-Concept findings on Invion’s INV043 API and how the unique technology could be a new way to treat a range of cancers